You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperkeratosis

Showing 26 - 50 of 530
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Skin Disease, Vulvar Lichen Sclerosus Trial in Frauenfeld (FotonaSmooth SP® Spectro laser device, Clobetasol propionate

Active, not recruiting
  • Chronic Skin Disease
  • Vulvar Lichen Sclerosus
  • FotonaSmooth SP® Spectro laser device
  • Clobetasol propionate 0.05% ointment
  • Frauenfeld, Thurgau, Switzerland
    Cantonal Hospital Frauenfeld
Feb 2, 2022

Oily Skin Trial in Seoul (PLADUO(PX1000))

Completed
  • Oily Skin
  • PLADUO(PX1000)
  • Seoul, Korea, Republic of
    GangnamSeverance Hospital
Jun 1, 2021

Vulvar Lichen Sclerosus Trial in Bern (Clobetasol propionate 0.05%, Progesterone 8%)

Terminated
  • Vulvar Lichen Sclerosus
  • Clobetasol propionate 0.05%
  • Progesterone 8%
  • Bern, Switzerland
    Dep. of Obstetrics and Gynecology, Bern University Hospital
Mar 21, 2022

Vulvar Lichen Sclerosus Trial in Jacksonville, Cincinnati, South Burlington (The CO2RE® System)

Completed
Has Results
  • Vulvar Lichen Sclerosus
  • The CO2RE® System
  • Jacksonville, Florida
  • +3 more
Feb 23, 2022

Atopic Dermatitis, Eczema Trial (Lebrikizumab)

Not yet recruiting
  • Atopic Dermatitis
  • Eczema
  • Lebrikizumab
  • (no location specified)
Aug 7, 2023

Venous Leg Ulcer Trial in United States (Marine polysaccharide dressing, Carboxymethylcellulose dressing)

Recruiting
  • Venous Leg Ulcer
  • Marine polysaccharide dressing
  • Carboxymethylcellulose dressing
  • Fresno, California
  • +4 more
Nov 2, 2021

Blepharitis Trial in Newport Beach (NCX 4251, Placebo)

Completed
Has Results
  • Blepharitis
  • NCX 4251
  • Placebo
  • Newport Beach, California
    Eye Research Foundation
Nov 17, 2022

Vulva Lichen Sclerosus Trial in Xi'an (device, combination product, drug)

Recruiting
  • Vulva Lichen Sclerosus
  • CO2 fractional laser
  • +2 more
  • Xi'an, Shaanxi, China
    Dermatology Derpartment of Xijing Hospital
Feb 7, 2022

Platelet Rich Plasma Trial in Sohag (intralesional platelet rich plasma, Oral terbinafine)

Not yet recruiting
  • Platelet Rich Plasma
  • intralesional platelet rich plasma
  • Oral terbinafine
  • Sohag, Egypt
    Sohag University Hospital
Nov 11, 2021

Actinic Porokeratosis Trial in Charleston (Lovastatin 2%, 2% Cholesterol Cream, Lovastatin 2%)

Unknown status
  • Actinic Porokeratosis
  • Lovastatin 2%, 2% Cholesterol Cream
  • Lovastatin 2%
  • Charleston, South Carolina
    Medical University of South Carolina
Jan 12, 2021

Psoriatic Nail, Psoriasis Vulgaris, Psoriasis Trial in Birmingham (Apremilast)

Completed
Has Results
  • Psoriatic Nail
  • +2 more
  • Birmingham, Alabama
    The Kirklin Clinic
Sep 29, 2022

Chronic Hand Eczema Trial in Bordeaux, Montpellier, Toulouse (Dupilumab, )

Recruiting
  • Chronic Hand Eczema
  • Bordeaux, France
  • +2 more
Sep 3, 2021

Actinic Keratosis, Sun Damaged Skin, Solar Keratosis Trial (Ablative Fractional Carbon Dioxide (CO2) Laser, Microdermabrasion)

Completed
Has Results
  • Actinic Keratosis
  • +3 more
  • Ablative Fractional Carbon Dioxide (CO2) Laser
  • Microdermabrasion
  • (no location specified)
Sep 13, 2022

Hand Eczema Trial in Worldwide (Ruxolitinib cream, Vehicle)

Withdrawn
  • Hand Eczema
  • Phoenix, Arizona
  • +48 more
Nov 14, 2022

Hypertrophic Scar Trial in Rochester (Pentamidine Isethionate, Silicone Gels)

Recruiting
  • Hypertrophic Scar
  • Pentamidine Isethionate
  • Silicone Gels
  • Rochester, Minnesota
    Mayo Clinic
Oct 20, 2021

Plaque Psoriasis Trial (TAK-279, Placebo, Apremilast)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Oct 12, 2023

Breast Cancer, Hormone Receptor Positive Tumor Trial in Tampa (Durvalumab, Anastrozole 1mg, Letrozole 2.5mg)

Terminated
Has Results
  • Breast Cancer
  • Hormone Receptor Positive Tumor
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
May 27, 2022

KPPP1, Pachyonychia, Congenital Trial in Tel Aviv (Serum chemistry, Hematology, Urinalysis)

Recruiting
  • KPPP1
  • Pachyonychia, Congenital
  • Serum chemistry
  • +7 more
  • Tel Aviv, Israel
    Sourasky Medical Center - Ichilov Hospital
Jun 23, 2022

Systemic scleRosis and Progressive Digital ulcEr Disease.

Recruiting
  • Scleroderma
  • +4 more
    • Athens, Greece
      Laikon Hospital of Athens
    Mar 22, 2022

    Lupus Erythematosus, Cutaneous Trial in Germany (GSK2646264 1%, Placebo)

    Completed
    Has Results
    • Lupus Erythematosus, Cutaneous
    • GSK2646264 1%
    • Placebo
    • Tuebingen, Baden-Wuerttemberg, Germany
    • +4 more
    Mar 11, 2021

    Chronic Hand Eczema (CHE) Trial in Worldwide (Ruxolitinib cream, Vehicle)

    Withdrawn
    • Chronic Hand Eczema (CHE)
    • Birmingham, Alabama
    • +38 more
    Nov 7, 2022

    TD01 Master Study (Safety and Efficacy Study)

    Completed
    Has Results
    • ICD/CRT-D Indication
    • First ICD/CRT-D implantation or upgrade from pacemaker
    • Linz, Austria
    • +4 more
    Oct 27, 2021

    Plaque Psoriasis Trial (TAK-279, Placebo, Apremilast)

    Not yet recruiting
    • Plaque Psoriasis
    • (no location specified)
    Oct 25, 2023

    Lichen Planus, Oral Trial in Catania (Oral lichen clinical Healing evaluation)

    Completed
    • Lichen Planus, Oral
    • Oral lichen clinical Healing evaluation
    • Catania, CT, Italy
      University of Catania
    Jan 20, 2021

    Lichen Sclerosus Trial in Herne (Clobetasol 0.05% Emollient Top Cream, Non-ablative CO2 Laser)

    Recruiting
    • Lichen Sclerosus
    • Clobetasol 0.05% Emollient Top Cream
    • Non-ablative CO2 Laser
    • Herne, NRW, Germany
      Marien Hospital Herne
    Nov 3, 2021